Evidence map›Paper›PMID 19220138›Full record

Trial reportThe Journal of infectious diseases2009

Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda.

Aaron A R Tobian, Blake Charvat, Victor Ssempijja, Godfrey Kigozi, David Serwadda, Frederick Makumbi, Boaz Iga, Oliver Laeyendecker, Melissa Riedesel, Amy Oliver and 5 more

2 registry-linked trialsOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in The Journal of infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00124878 phase3unknown statusnot on this map

Trial of Male Circumcision: HIV, STD and Behavioral Effects in Men, Women and the Community

TypeinterventionalSponsorWawer, Maria J., M.D.Ran2003 to 2009Enrolled5,200ConditionsHIV Infections, Sexually Transmitted Diseases, Papillomavirus Infections, Genital HerpesArmsMale circumcision
NCT00425984 phase3completednot on this map

Randomized Trial of Male Circumcision for HIV Prevention, Rakai, Uganda

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2002 to 2006Enrolled5,000ConditionsHIV Infections, Herpesvirus 2, Human, Syphilis, Genital Diseases, MaleArmsAdult male circumcision
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Novel penile circumcision suturing devices versus the shang ring for adult male circumcision: a prospective study.International braz j urol : official journal of the Brazilian Society of Urology
    Trial
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Females' Peer Influence and Support for Adolescent Males Receiving Voluntary Medical Male Circumcision Services.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  18. Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (abridged version).Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2018
    Article
  19. Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version).Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Aaron A R TobianDepartment of Pathology, Johns Hopkins University School of Medicine, Maryland, USA. atobian1@jhmi.edu
Blake Charvat
Victor Ssempijja
Godfrey Kigozi
David Serwadda
Frederick Makumbi
Boaz Iga
Oliver Laeyendecker
Melissa Riedesel
Amy Oliver
Michael Z Chen
Steven J Reynolds
Maria J Wawer
Ronald H Gray
Thomas C Quinn
Johns Hopkins University · USMakerere University · UGRakai Health Sciences Program · UGJohns Hopkins Medicine · USNational Institute of Allergy and Infectious Diseases · US

Funding

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Male Circumcision Trial for HIV Prevention, Rakai-UgandaU01AI051171 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2002 to 2006
$8.9M
Immunopathogenesis Of Chlamydia trachomatis InfectionZIAAI000358 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI QUINN, THOMAS · 2009 to 2022
$7.0M
INTERNATIONAL STUDIES ON THE ACQUIRED IMMUNODEFICIENCY SYNDROMEZ01AI000361 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI QUINN, THOMAS · 1985 to 2008
$3.1M
International Training/Research in Population and Health, UgandaD43TW001508 · FIC · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2000 to 2010
$2.1M
SPECIAL POSTDOCTORAL RESEARCH PROGRAM IN AIDST22TW000015 · FIC · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SCOTT, GWENDOLYN B. · 1988 to 1999
–
FIC NIH HHS 5D43TW001508FIC NIH HHS D43TW00015FIC NIH HHS D43 TW001508FIC NIH HHS T22 TW000015Intramural NIH HHS Z01 AI000361Intramural NIH HHS Z99 AI999999NIAID NIH HHS U01 AI051171NIAID NIH HHS U1AI51171
6 · The paper itself

Abstract

Little is known about risk factors for incident herpes simplex virus type 2 (HSV-2) infection among men in Africa. In a trial in Rakai, Uganda, 6396 men aged 15-49 years were evaluated for serological evidence of HSV-2, human immunodeficiency virus (HIV), and syphilis infections at enrollment and at 6, 12, and 24 months. The prevalence of HSV-2 infection was 33.76%, and the incidence was 4.90 cases per 100 person-years. HSV-2 incidence increased with alcohol use with sexual intercourse (adjusted incidence rate ratio [adjIRR], 1.92 [95% confidence interval {CI}, 1.46-2.53]), decreased with consistent condom use (adjIRR, 0.56 [95% CI, 0.36-0.89]) and male circumcision (adjIRR, 0.70 [95% CI, 0.55-0.91]), and was not significantly affected by enrollment HIV status. Education on modifiable behavioral changes may reduce the acquisition of HSV-2. (ClinicalTrials.gov identifiers: NCT00425984 and NCT00124878 .).

Indexed as

Herpesvirus 2, HumanAdolescentAdultAlcohol DrinkingCircumcision, MaleCondomsConfidence IntervalsHerpes GenitalisHIV-1HIV-2HIV SeropositivityHumansIncidenceMaleMiddle AgedMultivariate Analysis

Identifiers

PMID19220138
PMCPMC2789195
OpenAlexW2160702926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.